INTERLEUKIN

Clinical trials for INTERLEUKIN explained in plain language.

Never miss a new study

Get alerted when new INTERLEUKIN trials appear

Sign up with your email to follow new studies for INTERLEUKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

MRNA vaccine takes on Hard-to-Treat cancers in early trial

Disease control Recruiting now

This early study tests a new mRNA vaccine (IL-22BP) for people with advanced solid tumors like sarcoma, head and neck cancer, or melanoma that have not responded to standard treatments. The vaccine is injected directly into tumors. Only 6 participants are enrolled to check safety…

Matched conditions: INTERLEUKIN

Phase: PHASE1 • Sponsor: Xingchen Peng • Aim: Disease control

Last updated Jun 27, 2026 08:07 UTC

INTERLEUKIN

Get alerted when new INTERLEUKIN trials appear

MRNA vaccine takes on Hard-to-Treat cancers in early trial